Showing 5,401 - 5,420 results of 28,838 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.69s Refine Results
  1. 5401

    Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

    Published 2018
    “…Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. …”
  2. 5402

    The changes of EFR3A expression in the organ of Corti in the animals treated with kanamycin and furosemide by western blotting. by Chen Nie (686387)

    Published 2015
    “…<p>TUJ1 protein, with a molecular weight of 50 KD, was identified as an internal reference. …”
  3. 5403
  4. 5404

    Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

    Published 2019
    “…When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
  5. 5405

    Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

    Published 2019
    “…When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ<sub>PL</sub> decreased by half, perhaps due to the increased energy gap between <sup>1</sup>CT and <sup>3</sup>LE. …”
  6. 5406

    4‑Aminoquinoline Antimalarials Containing a Benzyl­methyl­pyridyl­methyl­amine Group Are Active against Drug Resistant <i>Plasmodium falciparum</i> and Exhibit Oral Activity in Mic... by Mukesh C. Joshi (4670284)

    Published 2017
    “…These compounds exhibited significantly improved solubility and decreased lipophilicity and were potent against chloroquine-sensitive (NF54) and -resistant (Dd2 and 7G8) <i>P. falciparum</i> strains with 5/6 having IC<sub>50</sub> < 100 nM against the NF54 strain. …”
  7. 5407
  8. 5408

    Initial treatment regimen. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  9. 5409

    Patients baseline characteristics. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  10. 5410

    Overall survival. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  11. 5411

    Progression-free survival by treatment. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  12. 5412

    Maintenance regimen and adverse event management. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  13. 5413

    BCC-specific survival. by Shivani Patel (4742748)

    Published 2024
    “…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”
  14. 5414

    Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent by Biswadip Banerji (482320)

    Published 2018
    “…A series of triazole-substituted quinazoline hybrid compounds were designed and synthesized for anticancer activity targeting epidermal growth factor receptor (EGFR) tyrosine kinase. …”
  15. 5415

    Outcome of AEFIs. by Amma Frempomaa Asare (19751343)

    Published 2024
    “…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”
  16. 5416
  17. 5417

    Types of AEFIs reported by vaccine type in Ghana. by Amma Frempomaa Asare (19751343)

    Published 2024
    “…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”
  18. 5418

    Types of AEFIs reported. by Amma Frempomaa Asare (19751343)

    Published 2024
    “…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”
  19. 5419
  20. 5420

    Primers for real-time PCR (rat). by Hanhan Liu (568151)

    Published 2024
    “…<i>Jag2</i> upregulation was first confirmed in rats with sustained hypoxia-induced PH using publicly available gene expression data, experimental PH rat models and hypoxia induced rat PASMCs. Jag2 deficiency decreased oxidative stress injury, peripheral pulmonary vascular remodeling (0.276±0.020 vs. 0.451±0.033 μm, <i>P</i><0.001, <50μm), and right ventricular systolic pressure (36.8±3.033 vs. 51.8±4.245 mmHg, <i>P</i><0.001) in the chronic hypoxia-induced rat model of PH. …”